FSN Capital’s Acquisition of Majority Stake in Epista Life Science

Plesner advised FSN Capital on the deal. The leading Nordic private equity firm, FSN Capital, has signed an agreement to acquire a majority stake in Epista…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here